Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN : revenue, balance sheet and financial ratios

PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN is a French company founded 14 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in DIEMERINGEN (67430), this company of category PME shows in 2023 a net income positive of 356 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN (SIREN 538862897)
Indicator 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 355 864 € 369 741 € 286 536 € 269 344 € 317 941 € 285 552 € 300 680 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2023, PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN generates positive net income of 356 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2023: 301 k€ -> 356 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

355 864 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 37%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 66%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

36.731%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

66.258%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

72.0%

Solvency indicators evolution
PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN

Sector positioning

Debt ratio
36.73 2023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good

In 2023, the debt ratio of PHARMACIE DE DIEMERINGEN ... (36.73) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
66.26% 2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good +9 pts over 3 years

In 2023, the financial autonomy of PHARMACIE DE DIEMERINGEN ... (66.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 248.95. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

248.948

Liquidity indicators evolution
PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN

Sector positioning

Liquidity ratio
248.95 2023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Good +23 pts over 3 years

In 2023, the liquidity ratio of PHARMACIE DE DIEMERINGEN ... (248.95) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN is estimated at 4 199 008 € (range 2 553 618€ - 5 902 864€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
2553k€ 4199k€ 5902k€
4 199 008 € Range: 2 553 618€ - 5 902 864€
NAF 5 année 2023

Valuation method used

Net Income Multiple
355 864 € × 11.8x = 4 199 009 €
Range: 2 553 618€ - 5 902 864€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN

What is the revenue of PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN ?

The revenue of PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN profitable?

Yes, PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN generated a net profit of 356 k€ in 2023.

Where is the headquarters of PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN ?

The headquarters of PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN is located in DIEMERINGEN (67430), in the department Bas-Rhin.

Where to find the tax return of PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN ?

The tax return of PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN operate?

PHARMACIE DE DIEMERINGEN GENAY ZIMMERMANN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.